About Medivation

Medivation is an American biopharmaceutical company focused on rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation, in collaboration with Astellas, is currently developing enzalutamide for multiple stages of prostate cancer and for breast cancer. On August 31, 2012, Medivation and – more... 

Reviews

Overall

4.8
Based on 5 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
4.7
Compensation/Benefits
4.7
Job Security/Advancement
4.7
Management
4.8
Culture
5.0
Claim this company page
Headquarters
San Francisco, California
Links
Medivation website